| 产品详情 |
| Edit |   |
|---|
| Product Name | Darapladib |
|---|
| Description | MW: 666.78. Purity ≥98% by HPLC. Darapladib (SB-480848); is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor (IC50 of 0.25 nM). It produces sustained inhibition of plasma Lp-PLA2 activity in humans receiving intensive atorvastatin therapy. Lp-PLA2 inhibition with Darapladib also reduces the development of coronary atherosclerotic plaques. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [N-[2- (diethylamino) ethyl]-2-[[ (4-fluorophenyl) methyl]thio]-4; 5; 6; 7-tetrahydro-4-oxo-N-[[4'- (trifluoromethyl) [1; 1'-biphenyl]-4-yl]methyl]-] |
|---|
| Gene, Accession, CAS # | CAS: 356057-34-6 |
|---|
| Catalog # | MBS846406 |
|---|
| Price | |
|---|
| Order / More Info | Darapladib from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|